The Supervisory Board has unanimously decided to propose Roy Jakobs as the next President and CEO of Royal Philips to its General Meeting of Shareholders.
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
The stability is led by healthy demand in the domestic and emerging markets
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment
Subscribe To Our Newsletter & Stay Updated
